The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 29, 2019

Filed:

Aug. 12, 2014
Applicant:

Terumo Kabushiki Kaisha, Shibuya-ku, JP;

Inventors:

Keiko Yamashita, Ashigarakami-gun, JP;

Shigenori Nozawa, Ashigarakami-gun, JP;

Katsumi Morimoto, Ashigarakami-gun, JP;

Assignee:

TERUMO KABUSHIKI KAISHA, Shibuya-Ku, Tokyo, JP;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61L 29/08 (2006.01); A61L 29/16 (2006.01); A61L 31/16 (2006.01);
U.S. Cl.
CPC ...
A61L 29/08 (2013.01); A61L 29/16 (2013.01); A61L 31/16 (2013.01); A61L 2300/416 (2013.01); A61L 2300/63 (2013.01); A61L 2420/02 (2013.01); A61L 2420/06 (2013.01);
Abstract

A method of treating peripheral artery diseases in lower limbs by providing a medical device having an expandable member having a drug coating layer which has a crystalline morphological form including a plurality of crystal particles of a water-insoluble drug regularly arranged and uniformly sized on the surface of the medical device, inserting the medical device in peripheral blood vessels, expanding the expandable member, pressing the drug coating layer to a blood vessel wall such that at least part of the plurality of crystals are transferred to the blood vessel wall, and deflating the expandable member such that a pharmacokinetics profile is presented in which a drug concentration in the blood vessels is kept for the inhibition of smooth muscle cell proliferation in a high drug-concentration period of time, and for the non-inhibition of endothelial cell growth in a later low drug-concentration period of time.


Find Patent Forward Citations

Loading…